Minimal impact of anticoagulant on in vitro whole blood quality throughout a 35‐day cold‐storage regardless of leukoreduction timing
暂无分享,去创建一个
[1] S. Brunskill,et al. The difference in potential harms between whole blood and component blood transfusion in major bleeding: a rapid systematic review and meta-analysis of RCTs , 2021, Transfusion Medicine Reviews.
[2] R. Cardigan,et al. A comparison of platelet function in cold‐stored whole blood and platelet concentrates , 2021, Transfusion.
[3] V. Chinchilli,et al. Whole blood versus component therapy for haemostatic resuscitation of major bleeding: a protocol for a systematic review and meta-analysis , 2021, BMJ Open.
[4] S. Nicholson,et al. Efficacy and Safety of Whole Blood Transfusion in Non-Trauma Patients. , 2021, The American surgeon.
[5] V. Bhakta,et al. Cold‐stored leukoreduced whole blood: Extending the time between donation and filtration has minimal impact on in vitro quality , 2021, Transfusion.
[6] J. Holcomb,et al. A new definition for massive transfusion in the modern era of whole blood resuscitation , 2021, Transfusion.
[7] T. Hervig,et al. Re‐introducing whole blood for transfusion: considerations for blood providers , 2020, Vox sanguinis.
[8] M. Franchini,et al. The use of whole blood in traumatic bleeding: a systematic review , 2020, Internal and Emergency Medicine.
[9] M. Fontaine,et al. Current state of whole blood transfusion for civilian trauma resuscitation , 2020, Transfusion.
[10] Henry E. Wang,et al. Whole blood transfusion versus component therapy in trauma resuscitation: a systematic review and meta‐analysis , 2020, Journal of the American College of Emergency Physicians open.
[11] T. Hervig,et al. Cold‐stored leukoreduced CPDA‐1 whole blood: in vitro quality and hemostatic properties , 2020, Transfusion.
[12] W. Dorlac,et al. Effects of whole blood leukoreduction on platelet function and hemostatic parameters , 2019, Transfusion medicine.
[13] B. Long,et al. Whole Blood in Trauma: A Review for Emergency Clinicians. , 2019, The Journal of emergency medicine.
[14] Parvez M Lokhandwala,et al. Hemostatic properties of cold‐stored whole blood leukoreduced using a platelet‐sparing versus a non–platelet‐sparing filter , 2019, Transfusion.
[15] M. A. Meledeo,et al. Optimizing whole blood storage: hemostatic function of 35‐day stored product in CPD, CP2D, and CPDA‐1 anticoagulants , 2019, Transfusion.
[16] Shawn C. Nessen,et al. Whole Blood Transfusion. , 2018, Military medicine.
[17] D. Devine,et al. Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols , 2017, Transfusion.
[18] D. Devine,et al. Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method , 2015, Transfusion.
[19] R. C. Dennis,et al. Viability and function of red blood cell concentrates stored at 4 degrees C for 35 days in CPDA‐1, CPDA‐2, or CPDA‐3 , 1982, Transfusion.